Stark Pharma Private Limited, a active private limited company, was established on 26 December 2014 in Hyderabad, Telangana, India. Engaging in hr outsourcing & talent management within the information and communication sector, it holds CIN: U72900TG2014PTC097007. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.52 Cr.
Formerly known as Stark Pharma Soft Tech Private Limited. It upholds a compliant status. Its leadership includes Teja Sravanthi Darapureddy (Director), Parvataneni Ramamohana Rao (Director), Madhukiran Parvathaneni (Director). Past directors included Garikapati Ravi Kiran, Prathipati Vishnumanasa, Radha Vemuri. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit 512, 5Th Floor Manjeera Majestic Commercial, Jntu Hitec, Hcity Road, Hyderabad, Telangana, 500072.
U72900TG2014PTC097007
097007
26 December 2014
₹5.00 Cr
₹4.52 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Stark Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Teja Sravanthi Darapureddy | Director | 19 Apr 2024 | Current |
| Parvataneni Ramamohana Rao | Director | 01 Dec 2018 | Current |
| Madhukiran Parvathaneni | Director | 18 Jul 2025 | Current |
| Prathipati Kalyani | Director | 17 Mar 2023 | Current |
| Venkateswararao Parvathaneni | Director | 26 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Nov 2022 | Past |
| Pramod Abcsdd | Director | 23 Dec 2019 | Past |
| Pramod Abcsdd | Director | 12 Jul 2023 | Past |
| Pramod Abcsdd | Director | 24 Jun 2020 | Past |
| Pramod Abcsdd | Managing Director | 23 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 15 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stark Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 175.49% increase. The company also saw a substantial improvement in profitability, with a 143.65% increase in profit. The company's net worth moved up by a moderate rise of 3.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Stark Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Stark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stark Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Madhukiran Parvathaneni was appointed as a Director was appointed as a Director on 18 Jul 2025 & has been associated with this company since 4 months 14 days . was recorded as a recent event.
Progress on Venkateswararao Parvathaneni was appointed as a Director was appointed as a Director on 26 Apr 2025 & has been associated with this company since 7 months 5 days . was documented.
Progress on Stark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Teja Sravanthi Darapureddy was appointed as a Director was appointed as a Director on 19 Apr 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
Stark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Prathipati Kalyani was appointed as a Director was appointed as a Director on 17 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
The CIN of Stark Pharma Private Limited is U72900TG2014PTC097007.
Stark Pharma Private Limited is headquartered at Unit 512, 5Th Floor Manjeera Majestic Commercial, Jntu Hitec, Hcity Road, Hyderabad, Telangana, 500072.
Stark Pharma Private Limited was incorporated on 26 December 2014.
The current directors of Stark Pharma Private Limited are
The primary industry of Stark Pharma Private Limited is Information And Communication.
Stark Pharma Private Limited is unlisted.
The authorized capital of Stark Pharma Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.52 Cr.
The compliance status of Stark Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX